Home › NDC Lookup › RxCUI directory › RxCUI 729931

24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor] — RxCUI 729931

RxNorm drug concept · Semantic branded drug
RxCUI 729931 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI729931
Official name24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Effexor 150 MG Extended Release Oral Capsule; Effexor XR 150 MG 24HR Extended Release Oral Capsule; Effexor XR 150 MG (as venlafaxine hydrochloride) 24 HR Extended Release Oral Capsule; Effexor XR 150 MG 24 HR Extended Release Oral Capsule
FDA products mapped3
Package NDCs mapped6
Reported Medicaid activity (SDUD)488 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Venlafaxine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats major depressive disorder. Depending on the product, it is also used for social anxiety disorder, generalized anxiety disorder and panic disorder. Your pharmacist can con...
  • Take extended-release forms once a day with food, at about the same time each day. Swallow tablets and capsules whole. A capsule can be opened onto applesauce if swallowing is hard...
  • Nausea, sleepiness, dry mouth, sweating, constipation and loss of appetite are common. Some people have sexual side effects. Call your doctor if side effects are severe or don’t ea...
  • Please don’t stop suddenly. Stopping or cutting the dose quickly can cause dizziness, nausea, anxiety, insomnia and electric-shock feelings. Your prescriber will lower the dose gra...
📖 Read our full Venlafaxine guide →

🕸️ Concept Web — How 24 HR venlafaxine 150 MG Extended Release Oral C... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR venlafaxine 150 MG Extended Release Oral Capsule [Effexor] RxCUI 729931

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Venlafaxine 39786
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Effexor 151692
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Venlafaxine Extended Release Oral Capsule 452534
    • Venlafaxine Oral Product 1164574
    • Venlafaxine Pill 1164575
    • Venlafaxine Extended Release Oral Capsule [Effexor] 729928
    • Effexor Oral Product 1173219
    • Effexor Pill 1173220
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Venlafaxine 150 MG [Effexor] SBDC · 729930
  • Venlafaxine Extended Release Oral Capsule [Effexor] SBDF · 729928
  • Effexor Oral Product SBDG · 1173219
  • Effexor Pill SBDG · 1173220
  • Effexor BN · 151692

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 729931 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58151-0125-77 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-77) Effexor XR Viatris Specialty LLC 2024-07-17
58151-0125-93 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-125-93) Effexor XR Viatris Specialty LLC 2024-07-17
58151-0126-77 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-126-77) Effexor XR Viatris Specialty LLC 2024-10-30
58151-0126-93 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-126-93) Effexor XR Viatris Specialty LLC 2024-10-30
58151-0127-77 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-127-77) Effexor XR Viatris Specialty LLC 2024-08-01
58151-0127-93 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (58151-127-93) Effexor XR Viatris Specialty LLC 2025-07-01
Observed labelers: Viatris Specialty LLC (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.